Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2011 (2011), Article ID 587495, 16 pages
http://dx.doi.org/10.1155/2011/587495
Review Article

Microarray Evidences the Role of Pathologic Adipose Tissue in Insulin Resistance and Their Clinical Implications

1Department of Endocrinology, S. M. S. Medical College, India
2Institute of Genomics and Integrative Biology, Mall Road, New Delhi 110007, India
3Department of Pharmacology, S. M. S. Medical College, J. L. Marg, Jaipur 302004, India

Received 1 December 2010; Accepted 21 February 2011

Academic Editor: Eliot Brinton

Copyright © 2011 Sandeep Kumar Mathur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Del Prato, R. C. Bonadonna, E. Bonora et al., “Characterization of cellular defects of insulin action in type 2 (non- insulin-dependent) diabetes mellitus,” Journal of Clinical Investigation, vol. 91, no. 2, pp. 484–494, 1993. View at Google Scholar · View at Scopus
  2. G. M. Reaven, “Role of insulin resistance in human disease,” Diabetes, vol. 37, no. 12, pp. 1595–1607, 1988. View at Google Scholar · View at Scopus
  3. G. M. Reaven, “Pathophysiology of insulin resistance in human disease,” Physiological Reviews, vol. 75, no. 3, pp. 473–486, 1995. View at Google Scholar · View at Scopus
  4. M. Koffler, L. C. Ramirez, and P. Raskin, “Insulin resistance and diabetes, mechanism and possible intervention,” Diabetes Research and Clinical Practice, vol. 7, no. 2, pp. 83–98, 1989. View at Google Scholar · View at Scopus
  5. J. Vague, “The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease,” The American Journal of Clinical Nutrition, vol. 4, no. 1, pp. 20–34, 1956. View at Google Scholar · View at Scopus
  6. E. S. Ford, “Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S,” Diabetes Care, vol. 28, no. 11, pp. 2745–2749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Adams, S. Appleton, D. H. Wilson et al., “Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition,” Diabetes Care, vol. 28, no. 11, pp. 2777–2779, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Ford, W. H. Giles, and A. H. Mokdad, “Increasing prevalence of the metabolic syndrome among U.S. adults,” Diabetes Care, vol. 27, no. 10, pp. 2444–2449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Reaven, “The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals,” Endocrinology and Metabolism Clinics of North America, vol. 33, no. 2, pp. 283–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kahn, J. Buse, E. Ferrannini, and M. Stern, “The metabolic syndrome: time for a critical appraisal—joint statement from the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetes Care, vol. 28, no. 9, pp. 2289–2304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. C. W. Lau, “Metabolic syndrome: perception or reality?” Current Atherosclerosis Reports, vol. 11, no. 4, pp. 264–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. H. Kim and G. M. Reaven, “The metabolic syndrome: one step forward, two steps back,” Diabetes & Vascular Disease Research, vol. 1, no. 2, pp. 68–75, 2004. View at Google Scholar · View at Scopus
  13. G. M. Reaven, “The metabolic syndrome: Is this diagnosis necessary?” American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1237–1247, 2006. View at Google Scholar · View at Scopus
  14. H. E. Bays, J. M. González-Campoy, R. R. Henry et al., “Is adiposopathy (sick fat) an endocrine disease?” International Journal of Clinical Practice, vol. 62, no. 10, pp. 1474–1483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Bays and C. A. Dujovne, “Adiposopathy is a more rational treatment target for metabolic disease than obesity alone,” Current Atherosclerosis Reports, vol. 8, no. 2, pp. 144–156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Bays, “Adiposopathy: role of adipocyte factors in a new paradigm,” Expert Review of Cardiovascular Therapy, vol. 3, no. 2, pp. 187–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. H. Andreasen and G. Andersen, “Gene-environment interactions and obesity—further aspects of genomewide association studies,” Nutrition, vol. 25, no. 10, pp. 998–1003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Vockley, “Metabolism as a complex genetic trait, a systems biology approach: Implications for inborn errors of metabolism and clinical diseases,” Journal of Inherited Metabolic Disease, vol. 31, no. 5, pp. 619–629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. O. Schulz, P. H. Bennett, E. Ravussin et al., “Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S,” Diabetes Care, vol. 29, no. 8, pp. 1866–1871, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. G. Nelson, M. L. Sievers, W. C. Knowler et al., “Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes,” Circulation, vol. 81, no. 3, pp. 987–995, 1990. View at Google Scholar · View at Scopus
  21. N. Abate, M. Chandalia, P. G. Snell, and S. M. Grundy, “Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2750–2755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Chandalia, N. Abate, A. Garg, J. Stray-Gundersen, and S. M. Grundy, “Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 7, pp. 2329–2335, 1999. View at Google Scholar · View at Scopus
  23. C. Dina, “New insights into the genetics of body weight,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 11, no. 4, pp. 378–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Pomp, D. Nehrenberg, and D. Estrada-Smith, “Complex genetics of obesity in mouse models,” Annual Review of Nutrition, vol. 28, pp. 331–345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Joy and R. A. Hegele, “Genetics of Metabolic syndrome: is there a role for phenomics?” Current Atherosclerosis Reports, vol. 10, no. 3, pp. 201–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. G. Comuzzie, J. T. Williams, L. J. Martin, and J. Blangero, “Searching for genes underlying normal variation in human adiposity,” Journal of Molecular Medicine, vol. 79, no. 1, pp. 57–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. F. C. MacKay, E. A. Stone, and J. F. Ayroles, “The genetics of quantitative traits: challenges and prospects,” Nature Reviews Genetics, vol. 10, no. 8, pp. 565–577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Cookson, L. Liang, G. Abecasis, M. Moffatt, and M. Lathrop, “Mapping complex disease traits with global gene expression,” Nature Reviews Genetics, vol. 10, no. 3, pp. 184–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Buechler and A. Schäffler, “Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets?” Endocrine, Metabolic and Immune Disorders—Drug Targets, vol. 7, no. 4, pp. 250–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. Permana, A. Del Parigi, and P. A. Tataranni, “Microarray gene expression profiling in obesity and insulin resistance,” Nutrition, vol. 20, no. 1, pp. 134–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. T. Nadler and A. D. Attie, “Please pass the chips: genomic insights into obesity and diabetes,” Journal of Nutrition, vol. 131, no. 8, pp. 2078–2081, 2001. View at Google Scholar · View at Scopus
  32. C. Weyer, J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley, “Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance,” Diabetologia, vol. 43, no. 12, pp. 1498–1506, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. B. G. Marques, D. B. Hausman, and R. J. Martin, “Association of fat cell size and paracrine growth factors in development of hyperplastic obesity,” American Journal of Physiology, vol. 275, no. 6, pp. R1898–R1908, 1998. View at Google Scholar · View at Scopus
  34. J. Smith, M. Al-Amri, P. Dorairaj, and A. Sniderman, “The adipocyte life cycle hypothesis,” Clinical Science, vol. 110, no. 1, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Arner, “Regional adipocity in man,” Journal of Endocrinology, vol. 155, no. 2, pp. 191–192, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Raz, R. Eldor, S. Cernea, and E. Shafrir, “Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage,” Diabetes/Metabolism Research and Reviews, vol. 21, no. 1, pp. 3–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Arner, “Regional differences in protein production by human adipose tissue,” Biochemical Society Transactions, vol. 29, no. 2, pp. 72–75, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. I. J. Bujalska, S. Kumar, and P. M Stewart, “Does central obesity reflect 'Cushing's disease of the omentum '?” Lancet, vol. 349, no. 9060, pp. 1210–1213, 1997. View at Google Scholar · View at Scopus
  39. M. C. Carr and J. D. Brunzell, “Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2601–2607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. P. Després, “Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease,” Journal of Endocrinological Investigation, vol. 29, no. 3, pp. 77–82, 2006. View at Google Scholar · View at Scopus
  41. R. N. Bergman, S. P. Kim, K. J. Catalano et al., “Why visceral fat is bad: mechanisms of the metabolic syndrome,” Obesity, vol. 14, supplement 1, pp. 16S–19S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Grundy, “Obesity, metabolic syndrome, and cardiovascular disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2595–2600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. C. M. Smas and H. S. Sul, “Control of adipocyte differentiation,” Biochemical Journal, vol. 309, no. 3, pp. 697–710, 1995. View at Google Scholar · View at Scopus
  47. S. R. Farmer, “Transcriptional control of adipocyte formation,” Cell Metabolism, vol. 4, no. 4, pp. 263–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. G. J. Hausman, J. T. Wright, and R. L. Richardson, “The influence of extracellular matrix substrata on preadipocyte development in serum-free cultures of stromal-vascular cells,” Journal of Animal Science, vol. 74, no. 9, pp. 2117–2128, 1996. View at Google Scholar · View at Scopus
  49. J. E. Rundhaug, “Matrix metalloproteinases and angiogenesis,” Journal of cellular and molecular medicine, vol. 9, no. 2, pp. 267–285, 2005. View at Google Scholar · View at Scopus
  50. J. Lilla, D. Stickens, and Z. Werb, “Metalloproteases and adipogenesis: a weighty subject,” American Journal of Pathology, vol. 160, no. 5, pp. 1551–1554, 2002. View at Google Scholar · View at Scopus
  51. J. M. Argilés, J. López-Soriano, V. Almendro, S. Busquets, and F. J. López-Soriano, “Cross-talk between skeletal muscle and adipose tissue: a link with obesity?” Medicinal Research Reviews, vol. 25, no. 1, pp. 49–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. T. J. Bartness, C. K. Song, H. Shi, R. R. Bowers, and M. T. Foster, “Brain-adipose tissue cross talk,” Proceedings of the Nutrition Society, vol. 64, no. 1, pp. 53–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Storz, H. Döppler, A. Wernig, K. Pfizenmaier, and G. Müller, “Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells. Palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/AKT stimulation and glucose uptake,” European Journal of Biochemistry, vol. 266, no. 1, pp. 17–25, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. C. M. Smas and H. S. Sul, “Control of adipocyte differentiation,” Biochemical Journal, vol. 309, no. 3, pp. 697–710, 1995. View at Google Scholar · View at Scopus
  55. H. Bays, L. Mandarino, and R. A. DeFronzo, “Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of Type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 463–478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Heilbronn, S. R. Smith, and E. Ravussin, “Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus,” International Journal of Obesity, vol. 28, supplement 4, pp. S12–S21, 2004. View at Publisher · View at Google Scholar
  57. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. N. Fain, S. W. Bahouth, and A. K. Madan, “TNFα release by the nonfat cells of human adipose tissue,” International Journal of Obesity, vol. 28, no. 4, pp. 616–622, 2004. View at Publisher · View at Google Scholar
  59. J. N. Fain, D. S. Tichansky, and A. K. Madan, “Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes,” Metabolism, vol. 55, no. 8, pp. 1113–1121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Patsouris, P. P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels, “Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals,” Cell Metabolism, vol. 8, no. 4, pp. 301–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Wentworth, G. Naselli, W. A. Brown et al., “Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity,” Diabetes, vol. 59, no. 7, pp. 1648–1656, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Bays and C. Ballantyne, “Adiposopathy: why do adiposity and obesity cause metabolic disease?” Future Lipidology, vol. 1, no. 4, pp. 389–420, 2006. View at Google Scholar
  63. Wood I. S. and P. Trayhurn, “Adipokines and the signaling role of adipose tissue in inflammation and obesity,” Future Lipidology, vol. 1, no. 1, pp. 81–89, 2006. View at Google Scholar
  64. L. Lionetti, M. P. Mollica, A. Lombardi, G. Cavaliere, G. Gifuni, and A. Barletta, “From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 2, pp. 146–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Suganami, J. Nishida, and Y. Ogawa, “A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2062–2068, 2005. View at Publisher · View at Google Scholar
  66. M. Chee, R. Yang, E. Hubbell et al., “Accessing genetic information with high-density DNA arrays,” Science, vol. 274, no. 5287, pp. 610–614, 1996. View at Publisher · View at Google Scholar · View at Scopus
  67. A. S. Ishkanian, C. A. Malloff, S. K. Watson et al., “A tiling resolution DNA microarray with complete coverage of the human genome,” Nature Genetics, vol. 36, no. 3, pp. 299–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Gresham, M. J. Dunham, and D. Botstein, “Comparing whole genomes using DNA microarrays,” Nature Reviews Genetics, vol. 9, no. 4, pp. 291–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Kim and T. Park, “DNA microarrays to define and search for genes associated with obesity,” Biotechnology Journal, vol. 5, no. 1, pp. 99–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. S. T. Nadler, J. P. Stoehr, K. L. Schueler, G. Tanimoto, B. S. Yandell, and A. D. Attie, “The expression of adipogenic genes is decreased in obesity and diabetes mellitus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 21, pp. 11371–11376, 2000. View at Google Scholar · View at Scopus
  71. J. Gómez-Ambrosi, V. Catalán, A. Diez-Caballero et al., “Gene expression profile of omental adipose tissue in human obesity,” The FASEB Journal, vol. 18, no. 1, pp. 215–217, 2004. View at Google Scholar · View at Scopus
  72. U. N. Das and A. A. Rao, “Gene expression profile in obesity and type 2 diabetes mellitus,” Lipids in Health and Disease, vol. 6, article 35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. F. E. Von Eyben, J. P. Kroustrup, J. F. Larsen, and J. Celis, “Comparison of gene expression in intra-abdominal and subcutaneous fat: a study of men with morbid obesity and nonobese men using microarray and proteomics,” Annals of the New York Academy of Sciences, vol. 1030, pp. 508–536, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Baranova, R. Collantes, S. J. Gowder et al., “Obesity-related differential gene expression in the visceral adipose tissue,” Obesity Surgery, vol. 15, no. 6, pp. 758–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. I. Dahlman and P. Arner, “Obesity and polymorphisms in genes regulating human adipose tissue,” International Journal of Obesity, vol. 31, no. 11, pp. 1629–1641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. H. Lee, S. Nair, E. Rousseau et al., “Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes,” Diabetologia, vol. 48, no. 9, pp. 1776–1783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Nair, Y. H. Lee, E. Rousseau et al., “Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians,” Diabetologia, vol. 48, no. 9, pp. 1784–1788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Darimont, O. Avanti, F. Blancher et al., “Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects,” International Journal of Obesity, vol. 32, no. 1, pp. 112–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Jernås, J. Palming, K. Sjöholm et al., “Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression,” The FASEB Journal, vol. 20, no. 9, pp. 1540–1542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. S. K. Mathur, P. Chandra, S. Mishra, P. Ajmera, and P. Sharma, “Type-2 diabetes related intermediate phenotypic traits in north Indian diabetics,” Indian Journal of Clinical Biochemistry, vol. 22, no. 2, pp. 70–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Shah, Y. Lu, C. C. Hinkle et al., “Gene profiling of human adipose tissue during evoked inflammation in vivo,” Diabetes, vol. 58, no. 10, pp. 2211–2219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. M. E. Rausch, S. Weisberg, P. Vardhana, and D. V. Tortoriello, “Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration,” International Journal of Obesity, vol. 32, no. 3, pp. 451–463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Wu, S. Ghosh, X. D. Perrard et al., “T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity,” Circulation, vol. 115, no. 8, pp. 1029–1038, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, “Obesity induces a phenotypic switch in adipose tissue macrophage polarization,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 175–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. L. K. Heilbronn and L. V. Campbell, “Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity,” Current Pharmaceutical Design, vol. 14, no. 12, pp. 1225–1230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. J. M. Olefsky and C. K. Glass, “Macrophages, inflammation, and insulin resistance,” Annual review of physiology, vol. 72, pp. 219–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. A. O'Hara, F. L. Lim, D. J. Mazzatti, and P. Trayhurn, “Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium,” Pflugers Archiv European Journal of Physiology, vol. 458, no. 6, pp. 1103–1114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. M. E. Rausch, S. Weisberg, P. Vardhana, and D. V. Tortoriello, “Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration,” International Journal of Obesity, vol. 32, no. 3, pp. 451–463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Trayhurn, B. Wang, and I. S. Wood, “Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?” British Journal of Nutrition, vol. 100, no. 2, pp. 227–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Hosogai, A. Fukuhara, K. Oshima et al., “Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation,” Diabetes, vol. 56, no. 4, pp. 901–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Wang, I. S. Wood, and P. Trayhurn, “Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes,” Pflugers Archiv European Journal of Physiology, vol. 455, no. 3, pp. 479–492, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. G. B. Di Gregorio, A. Yao-Borengasser, N. Rasouli et al., “Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone,” Diabetes, vol. 54, no. 8, pp. 2305–2313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. H. Sell and J. Eckel, “Monocyte chemotactic protein-1 and its role in insulin resistance,” Current Opinion in Lipidology, vol. 18, no. 3, pp. 258–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Sartipy and D. J. Loskutoff, “Monocyte chemoattractant protein 1 in obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7265–7270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Chen, S. Mumick, C. Zhang et al., “Diet induction of monocyte chemoattractant protein-1 and its impact on obesity,” Obesity Research, vol. 13, no. 8, pp. 1311–1320, 2005. View at Google Scholar · View at Scopus
  97. C. A. Curat, A. Miranville, C. Sengenès et al., “From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes,” Diabetes, vol. 53, no. 5, pp. 1285–1292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Huber, F. W. Kiefer, M. Zeyda et al., “CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 8, pp. 3215–3221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. M. L. Gruen, M. Hao, D. W. Piston, and A. H. Hasty, “Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis,” American Journal of Physiology, vol. 293, no. 5, pp. C1481–C1488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Kamei, T. Suganami, T. Ehara et al., “Increased expression of DNA methyltransferase 3a in obese adipose tissue: studies with transgenic mice,” Obesity, vol. 18, no. 2, pp. 314–321, 2010. View at Publisher · View at Google Scholar
  101. F. M. Gregoire, C. M. Smas, and H. S. Sul, “Understanding adipocyte differentiation,” Physiological Reviews, vol. 78, no. 3, pp. 783–809, 1998. View at Google Scholar · View at Scopus
  102. S. R. Farmer, “Transcriptional control of adipocyte formation,” Cell Metabolism, vol. 4, no. 4, pp. 263–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. X. Guo and K. Liao, “Analysis of gene expression profile during 3T3-L1 preadipocyte differentiation,” Gene, vol. 251, no. 1, pp. 45–53, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Soukas, N. D. Socci, B. D. Saatkamp, S. Novelli, and J. M. Friedman, “Distinct transcriptional profiles of adipogenesis in vivo and in vitro,” Journal of Biological Chemistry, vol. 276, no. 36, pp. 34167–34174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. G. R. Burton, YU. Guan, R. Nagarajan, and R. E. McGehee, “Microarray analysis of gene expression during early adipocyte differentiation,” Gene, vol. 293, no. 1-2, pp. 21–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. G. R. Burton, R. Nagarajan, C. A. Peterson, and R. E. McGehee, “Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis,” Gene, vol. 329, no. 1-2, pp. 167–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. B. A. Jessen and G. J. Stevens, “Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts,” Gene, vol. 299, no. 1-2, pp. 95–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. D. L. Gerhold, F. Liu, G. Jiang et al., “Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-γ agonists,” Endocrinology, vol. 143, no. 6, pp. 2106–2118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Hsiao, D. S. Worrall, J. M. Olefsky, and S. Subramaniam, “Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes,” Bioinformatics, vol. 20, no. 17, pp. 3108–3127, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Gómez-Ambrosi, V. Catalán, A. Diez-Caballero et al., “Gene expression profile of omental adipose tissue in human obesity,” The FASEB Journal, vol. 18, no. 1, pp. 215–217, 2004. View at Google Scholar · View at Scopus
  111. H. Hackl, T. R. Burkard, A. Sturn et al., “Molecular processes during fat cell development revealed by gene expression profiling and functional annotation,” Genome Biology, vol. 6, no. 13, article 108, 2005. View at Publisher · View at Google Scholar
  112. J. Liu, S. M. DeYoung, M. Zhang, M. Zhang, A. Cheng, and A. R. Saltiel, “Changes in integrin expression during adipocyte differentiation,” Cell Metabolism, vol. 2, no. 3, pp. 165–177, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Pantoja, J. T. Huff, and K. R. Yamamoto, “Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro,” Molecular Biology of the Cell, vol. 19, no. 10, pp. 4032–4041, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. J. S. Huo, R. C. McEachin, T. X. Cui et al., “Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH,” Journal of Biological Chemistry, vol. 281, no. 7, pp. 4132–4141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. P. Åkerblad, R. Månsson, A. Lagergren et al., “Gene expression analysis suggests that EBF-1 and PPARγ2 induce adipogenesis of NIH-3T3 cells with similar efficiency and kinetics,” Physiological Genomics, vol. 23, no. 2, pp. 206–216, 2005. View at Publisher · View at Google Scholar
  116. A. Baudry, Z.-Z. Yang, and B. A. Hemmings, “PKBα is required for adipose differentiation of mouse embryonic fibroblast,” Journal of Cell Science, vol. 119, no. 5, pp. 889–897, 2006. View at Publisher · View at Google Scholar
  117. M. Christian, E. Kiskinis, D. Debevec, G. Leonardsson, R. White, and M. G. Parker, “RIP140-targeted repression of gene expression in adipocytes,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9383–9391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. T. C. Otto, R. R. Bowers, and M. D. Lane, “BMP-4 treatment of C3H10T1/2 stem cells blocks expression of MMP-3 and MMP-13,” Biochemical and Biophysical Research Communications, vol. 353, no. 4, pp. 1097–1104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. Y. H. Tseng, A. J. Butte, E. Kokkotou et al., “Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin,” Nature Cell Biology, vol. 7, no. 6, pp. 601–611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. J. A. Timmons, K. Wennmalm, O. Larsson et al., “Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 11, pp. 4401–4406, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. S. C. Hung, C. F. Chang, H. L. Ma, T. H. Chen, and L. Low-Tone Ho, “Gene expression profiles of early adipogenesis in human mesenchymal stem cells,” Gene, vol. 340, no. 1, pp. 141–150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. I. Sekiya, B. L. Larson, J. T. Vuoristo, J. G. Cui, and D. J. Prockop, “Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs),” Journal of Bone and Mineral Research, vol. 19, no. 2, pp. 256–264, 2004. View at Publisher · View at Google Scholar · View at Scopus
  123. T. Nakamura, S. Shiojima, Y. Hirai et al., “Temporal gene expression changes during adipogenesis in human mesenchymal stem cells,” Biochemical and Biophysical Research Communications, vol. 303, no. 1, pp. 306–312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Scheideler, C. Elabd, L.-E. Zaragosi et al., “Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis,” BMC Genomics, vol. 9, article 340, 2008. View at Publisher · View at Google Scholar
  125. S. Urs, C. Smith, B. Campbell et al., “Gene expression profiling in human preadipocytes and adipocytes by microarray analysis,” Journal of Nutrition, vol. 134, no. 4, pp. 762–770, 2004. View at Google Scholar · View at Scopus
  126. P. K. Tan, T. J. Downey, E. L. Spitznagel et al., “Evaluation of gene expression measurements from commercial microarray platforms,” Nucleic Acids Research, vol. 31, no. 19, pp. 5676–5684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Severgnini, S. Bicciato, E. Mangano et al., “Strategies for comparing gene expression profiles from different microarray platforms: application to a case-control experiment,” Analytical Biochemistry, vol. 353, no. 1, pp. 43–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Shi, L. H. Reid, W. D. Jones et al., “The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements,” Nature Biotechnology, vol. 24, no. 9, pp. 1151–1161, 2006. View at Publisher · View at Google Scholar
  129. K. Birsoy, Z. Chen, and J. Friedman, “Transcriptional regulation of adipogenesis by KLF4,” Cell Metabolism, vol. 7, no. 4, pp. 339–347, 2008. View at Publisher · View at Google Scholar
  130. Z. Chen, J. I. Torrens, A. Anand, B. M. Spiegelman, and J. M. Friedman, “Krox20 stimulates adipogenesis via C/EBPβ-dependent and -independent mechanisms,” Cell Metabolism, vol. 1, no. 2, pp. 93–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  131. L. C. Chao, S. J. Bensinger, C. J. Villanueva, K. Wroblewski, and P. Tontonoz, “Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1,” Molecular Endocrinology, vol. 22, no. 12, pp. 2596–2608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  132. W. S. Au, V. A. Payne, S. O'Rahilly, and J. J. Rochford, “The NR4A family of orphan nuclear receptors are not required for adipogenesis,” International Journal of Obesity, vol. 32, no. 2, pp. 388–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. T. Fumoto, T. Yamaguchi, F. Hirose, and T. Osumi, “Orphan nuclear receptor Nur77 accelerates the initial phase of adipocyte differentiation in 3T3-L1 cells by promoting mitotic clonal expansion,” Journal of Biochemistry, vol. 141, no. 2, pp. 181–192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. S. E. Ross, R. L. Erickson, I. Gerin et al., “Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor α in adipocyte metabolism,” Molecular and Cellular Biology, vol. 22, no. 16, pp. 5989–5999, 2002. View at Publisher · View at Google Scholar
  135. J. B. Seo, H. M. Moon, W. S. Kim et al., “Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor γ expression,” Molecular and Cellular Biology, vol. 24, no. 8, pp. 3430–3444, 2004. View at Publisher · View at Google Scholar
  136. M. A. Jimenez, P. Åkerblad, M. Sigvardsson, and E. D. Rosen, “Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade,” Molecular and Cellular Biology, vol. 27, no. 2, pp. 743–757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. Q. Tong, G. Dalgin, H. Xu, C. N. Ting, J. M. Leiden, and G. S. Hotamisligil, “Function of GATA transcription factors in preadipocyte-adipocyte transition,” Science, vol. 290, no. 5489, pp. 134–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  138. A. Jeltsch, “Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases,” ChemBioChem, vol. 3, no. 4, pp. 275–293, 2002. View at Google Scholar · View at Scopus
  139. T. Horii, S. Morita, M. Kimura, and I. Hatada, “Epigenetic regulation fo adipocyte differetiation by a Rho guanine nucleotide exchange factor, WGEF,” PLoS One, vol. 4, no. 6, Article ID e5809, 2009. View at Publisher · View at Google Scholar
  140. Y. Okada, H. Sakaue, T. Nagare, and M. Kasuga, “Diet-induced up-regulation of gene expression in adipocytes without changes in DNA methylation,” Kobe Journal of Medical Sciences, vol. 54, no. 5, pp. E241–E249, 2008. View at Google Scholar · View at Scopus
  141. N. Nakanishi, Y. Nakagawa, N. Tokushige et al., “The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice,” Biochemical and Biophysical Research Communications, vol. 385, no. 4, pp. 492–496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. T. Sun, M. Fu, A. L. Bookout, S. A. Kliewer, and D. J. Mangelsdorf, “MicroRNA let-7 regulates 3T3-L1 adipogenesis,” Molecular Endocrinology, vol. 23, no. 6, pp. 925–931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. N. A. Ducharme and P. E. Bickel, “Lipid droplets in lipogenesis and lipolysis,” Endocrinology, vol. 149, no. 3, pp. 942–949, 2008. View at Publisher · View at Google Scholar
  144. S. Kersten, “Mechanisms of nutritional and hormonal regulation of lipogenesis,” EMBO Reports, vol. 2, no. 4, pp. 282–286, 2001. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Jernås, J. Palming, K. Sjöholm et al., “Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression,” FASEB Journal, vol. 20, no. 9, pp. E832–E839, 2006. View at Publisher · View at Google Scholar
  146. K. Sjöholm, J. Palming, L. E. Olofsson et al., “A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2233–2239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. S. B. Su, W. Gong, JI. L. Gao et al., “A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells,” Journal of Experimental Medicine, vol. 189, no. 2, pp. 395–402, 1999. View at Publisher · View at Google Scholar · View at Scopus
  148. J. A. Stonik, A. T. Remaley, S. J. Demosky, E. B. Neufeld, A. Bocharov, and H. B. Brewer, “Serum Amyloid a promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells,” Biochemical and Biophysical Research Communications, vol. 321, no. 4, pp. 936–941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  149. M. Cortés-Canteli, M. Wagner, W. Ansorge, and A. Pérez-Castillo, “Microarray analysis supports a role for CCAAT/enhancer-binding protein-β in brain injury,” Journal of Biological Chemistry, vol. 279, no. 14, pp. 14409–14417, 2004. View at Publisher · View at Google Scholar · View at Scopus
  150. B. G. Gabrielsson, J. M. Johansson, M. Lönn et al., “High expression of complement components in omental adipose tissue in obese men,” Obesity Research, vol. 11, no. 6, pp. 699–708, 2003. View at Google Scholar · View at Scopus
  151. R. E. Pratley, D. B. Thompson, M. Prochazka et al., “An autosomal genomic scan for loci linked to prediabetic phenotypes in pima indians,” Journal of Clinical Investigation, vol. 101, no. 8, pp. 1757–1764, 1998. View at Google Scholar · View at Scopus
  152. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., “Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84–91, 2007. View at Publisher · View at Google Scholar
  153. T. Suganami, X. Yuan, Y. Shimoda et al., “Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated fatty Acid/Toll-like receptor 4 signaling and macrophage activation in obese adipose tissue,” Circulation Research, vol. 105, no. 1, pp. 25–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. M. Hassan, C. E. Yazidi, J. F. Landrier, D. Lairon, A. Margotat, and M. J. Amiot, “Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells,” Biochemical and Biophysical Research Communications, vol. 361, no. 1, pp. 208–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. M. Hassan, C. E. Yazidi, C. Malezet-Desmoulins, M. J. Amiot, and A. Margotat, “Gene expression profiling of 3T3-L1 adipocytes exposed to phloretin,” Journal of Nutritional Biochemistry, vol. 21, no. 7, pp. 645–652, 2010. View at Publisher · View at Google Scholar · View at Scopus
  156. Y. C. Wang, W. H. Kuo, C. Y. Chen et al., “Docosahexaenoic acid regulates serum amyloid A protein to promote lipolysis through down regulation of perilipin,” Journal of Nutritional Biochemistry, vol. 21, no. 4, pp. 317–324, 2010. View at Publisher · View at Google Scholar
  157. A. E. Reid, “Nonalcoholic steatohepatitis,” Gastroenterology, vol. 121, no. 3, pp. 710–723, 2001. View at Google Scholar · View at Scopus
  158. A. M. Diehl, “Nonalcoholic steatohepatitis,” Seminars in Liver Disease, vol. 19, no. 2, pp. 221–230, 1999. View at Google Scholar · View at Scopus
  159. E. E. Powell, W. G. E. Cooksley, R. Hanson, J. Searle, J. W. Halliday, and L. W. Powell, “The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years,” Hepatology, vol. 11, no. 1, pp. 74–80, 1990. View at Google Scholar · View at Scopus
  160. E. M. Brunt, C. G. Janney, A. M. Di Bisceglie, B. A. Neuschwander-Tetri, and B. R. Bacon, “Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions,” American Journal of Gastroenterology, vol. 94, no. 9, pp. 2467–2474, 1999. View at Publisher · View at Google Scholar · View at Scopus
  161. C. A. Matteoni, Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCullough, “Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity,” Gastroenterology, vol. 116, no. 6, pp. 1413–1419, 1999. View at Publisher · View at Google Scholar · View at Scopus
  162. E. Bugianesi, N. Leone, E. Vanni et al., “Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma,” Gastroenterology, vol. 123, no. 1, pp. 134–140, 2002. View at Publisher · View at Google Scholar · View at Scopus
  163. S. H. Caldwell, D. H. Oelsner, J. C. Iezzoni, E. E. Hespenheide, E. H. Battle, and C. J. Driscoll, “Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease,” Hepatology, vol. 29, no. 3, pp. 664–669, 1999. View at Google Scholar · View at Scopus
  164. A. Poonawala, S. P. Nair, and P. J. Thuluvath, “Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study,” Hepatology, vol. 32, no. 4, pp. 689–692, 2000. View at Google Scholar · View at Scopus
  165. J. Ong, Z. M. Younossi, V. Reddy et al., “Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease,” Liver Transplantation, vol. 7, no. 9, pp. 797–801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  166. F. Chiappini, A. Barrier, R. Saffroy et al., “Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray,” Laboratory Investigation, vol. 86, no. 2, pp. 154–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. R. Sreekumar, B. Rosado, D. Rasmussen, and M. Charlton, “Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis,” Hepatology, vol. 38, no. 1, pp. 244–251, 2003. View at Publisher · View at Google Scholar · View at Scopus
  168. O. Cheung, P. Puri, C. Eicken et al., “Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression,” Hepatology, vol. 48, no. 6, pp. 1810–1820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. D. E. Kelley, J. He, E. V. Menshikova, and V. B. Ritov, “Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes,” Diabetes, vol. 51, no. 10, pp. 2944–2950, 2002. View at Google Scholar · View at Scopus
  170. V. B. Schrauwen-Hinderling, M. E. Kooi, M. K. C. Hesselink et al., “Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects,” Diabetologia, vol. 50, no. 1, pp. 113–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  171. V. B. Ritov, E. V. Menshikova, J. He, R. E. Ferrell, B. H. Goodpaster, and D. E. Kelley, “Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes,” Diabetes, vol. 54, no. 1, pp. 8–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. R. Boushel, E. Gnaiger, P. Schjerling, M. Skovbro, R. Kraunsøe, and F. Dela, “Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle,” Diabetologia, vol. 50, no. 4, pp. 790–796, 2007. View at Publisher · View at Google Scholar · View at Scopus
  173. M. Mogensen, K. Sahlin, M. Fernström et al., “Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes,” Diabetes, vol. 56, no. 6, pp. 1592–1599, 2007. View at Publisher · View at Google Scholar
  174. R. Sreekumar, P. Halvatsiotis, J. C. Schimke, and K. Sreekumaran Nair, “Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment,” Diabetes, vol. 51, no. 6, pp. 1913–1920, 2002. View at Google Scholar · View at Scopus
  175. M. E. Patti, A. J. Butte, S. Crunkhorn et al., “Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8466–8471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  176. V. K. Mootha, C. M. Lindgren, K. F. Eriksson et al., “PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,” Nature Genetics, vol. 34, no. 3, pp. 267–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  177. V. Skov, D. Glintborg, S. Knudsen et al., “Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome,” Diabetes, vol. 56, no. 9, pp. 2349–2355, 2007. View at Publisher · View at Google Scholar
  178. C. M. Frederiksen, K. Højlund, L. Hansen et al., “Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes,” Diabetologia, vol. 51, no. 11, pp. 2068–2077, 2008. View at Publisher · View at Google Scholar
  179. X. Yang, R. Pratley, S. Tokraks, C. Bogardus, and P. Permana, “Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians,” Diabetologia, vol. 45, no. 11, pp. 1584–1593, 2002. View at Publisher · View at Google Scholar
  180. L. L. Nguyen, A. D. Kriketos, D. P. Hancock, I. D. Caterson, and G. S. Denyer, “Insulin resistance does not influence gene expression in skeletal muscle,” Journal of Biochemistry and Molecular Biology, vol. 39, no. 4, pp. 457–463, 2006. View at Google Scholar · View at Scopus
  181. I. Dahlman, K. Linder, E. A. Nordström et al., “Changes in adipose tissue gene expression with energy-restricted diets in obese women,” American Journal of Clinical Nutrition, vol. 81, no. 6, pp. 1275–1285, 2005. View at Google Scholar · View at Scopus
  182. F. Capel, E. Klimčáková, N. Viguerie et al., “Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization,” Diabetes, vol. 58, no. 7, pp. 1558–1567, 2009. View at Publisher · View at Google Scholar · View at Scopus
  183. K. Clément, N. Viguerie, C. Poitou et al., “Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects,” FASEB Journal, vol. 18, no. 14, pp. 1657–1669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  184. N. Viguerie, H. Vidal, P. Arner et al., “Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets,” Diabetologia, vol. 48, no. 1, pp. 123–131, 2005. View at Publisher · View at Google Scholar
  185. M. Kolehmainen, T. Salopuro, U. S. Schwab et al., “Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study,” International Journal of Obesity, vol. 32, no. 2, pp. 292–303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. S. J. van Dijk, E. J. M. Feskens, M. B. Bos et al., “A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome,” American Journal of Clinical Nutrition, vol. 90, no. 6, pp. 1656–1664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. W. J. Fu, T. E. Haynes, R. Kohli et al., “Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats,” Journal of Nutrition, vol. 135, no. 4, pp. 714–721, 2005. View at Google Scholar · View at Scopus
  188. W. Jobgen, W. J. Fu, H. Gao et al., “High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue,” Amino Acids, vol. 37, no. 1, pp. 187–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  189. C. Bolduc, M. Yoshioka, and J. St-Amand, “Transcriptomic characterization of the long-term dihydrotestosterone effects in adipose tissue,” Obesity, vol. 15, no. 5, pp. 1107–1132, 2007. View at Publisher · View at Google Scholar
  190. V. Catalán, J. Gómez-Ambrosi, A. Rodríguez et al., “Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans,” Journal of Molecular Medicine, vol. 87, no. 8, pp. 803–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  191. J. Zhang, Y. Wu, Y. Zhang, D. Leroith, D. A. Bernlohr, and X. Chen, “The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages,” Molecular Endocrinology, vol. 22, no. 6, pp. 1416–1426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  192. F. Aoki, S. Honda, H. Kishida et al., “Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 1, pp. 206–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  193. O. Šeda, L. Šedová, O. Oliyarnyk et al., “Pharmacogenomics of metabolic effects of rosiglitazone,” Pharmacogenomics, vol. 9, no. 2, pp. 141–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  194. V. Van Harmelen, A. Dicker, M. Rydén et al., “Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes,” Diabetes, vol. 51, no. 7, pp. 2029–2036, 2002. View at Google Scholar
  195. J. M. Ramis, N. L. W. Franssen-van Hal, E. Kramer et al., “Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects,” Cellular and Molecular Life Sciences, vol. 59, no. 11, pp. 1960–1971, 2002. View at Publisher · View at Google Scholar · View at Scopus
  196. M. Dolinková, I. Dostálová, Z. Lacinová et al., “The endocrine profile of subcutaneous and visceral adipose tissue of obese patients,” Molecular and Cellular Endocrinology, vol. 291, no. 1-2, pp. 63–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  197. P. Sebastiani, N. Timofeev, D. A. Dworkis, T. T. Perls, and M. H. Steinberg, “Genome-wide association studies and the genetic dissection of complex traits,” American Journal of Hematology, vol. 84, no. 8, pp. 504–515, 2009. View at Publisher · View at Google Scholar
  198. M. I. McCarthy and E. Zeggini, “Genome-wide association studies in type 2 diabetes,” Current Diabetes Reports, vol. 9, no. 2, pp. 164–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  199. R. B. Brem, G. Yvert, R. Clinton, and L. Kruglyak, “Genetic dissection of transcriptional regulation in budding yeast,” Science, vol. 296, no. 5568, pp. 752–755, 2002. View at Publisher · View at Google Scholar · View at Scopus
  200. V. G. Cheung and R. S. Spielman, “The genetics of variation in gene expression,” Nature Genetics, vol. 32, no. 5, pp. 522–525, 2002. View at Google Scholar · View at Scopus
  201. V. G. Cheung, L. K. Conlin, T. M. Weber et al., “Natural variation in human gene expression assessed in lymphoblastoid cells,” Nature Genetics, vol. 33, no. 3, pp. 422–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  202. E. E. Schadt, S. A. Monks, T. A. Drake et al., “Genetics of gene expression surveyed in maize, mouse and man,” Nature, vol. 422, no. 6929, pp. 297–302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  203. R. C. Jansen and J. P. Nap, “Genetical genomics: the added value from segregation,” Trends in Genetics, vol. 17, no. 7, pp. 388–391, 2001. View at Publisher · View at Google Scholar · View at Scopus
  204. M. Morloy, C. M. Molony, T. M. Weber et al., “Genetic analysis of genome-wide variation in human gene expression,” Nature, vol. 430, no. 7001, pp. 743–747, 2004. View at Publisher · View at Google Scholar
  205. V. G. Cheung, R. S. Spielman, K. G. Ewens, T. M. Weber, M. Morley, and J. T. Burdick, “Mapping determinants of human gene expression by regional and genome-wide association,” Nature, vol. 437, no. 7063, pp. 1365–1369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  206. Y. Chen, J. Zhu, P. Y. Lum et al., “Variations in DNA elucidate molecular networks that cause disease,” Nature, vol. 452, no. 7186, pp. 429–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  207. S. Wang, L. M. Sparks, H. Xie, F. L. Greenway, L. De Jonge, and S. R. Smith, “Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity,” International Journal of Obesity, vol. 33, no. 4, pp. 481–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  208. C. Buechler and A. Schäffler, “Does global gene expression analysis in type 2 diabetes provide an opportunity to identify highly promising drug targets?” Endocrine, Metabolic and Immune Disorders—Drug Targets, vol. 7, no. 4, pp. 250–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  209. S. T. Nadler and A. D. Attie, “Please pass the chips: genomic insights into obesity and diabetes,” Journal of Nutrition, vol. 131, no. 8, pp. 2078–2081, 2001. View at Google Scholar · View at Scopus
  210. P. A. Permana, S. Nair, and Y. H. Lee, “Application of DNA microarray to the study of human adipose tissue/cells,” Methods in Molecular Biology, vol. 456, pp. 141–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  211. D. Gresham, M. J. Dunham, and D. Botstein, “Comparing whole genomes using DNA microarrays,” Nature Reviews Genetics, vol. 9, no. 4, pp. 291–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  212. R. Brandt, R. Grützmann, A. Bauer et al., “DNA microarray analysis of pancreatic malignancies,” Pancreatology, vol. 4, no. 6, pp. 587–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  213. G. L. G. Miklos and R. Maleszka, “Microarray reality checks in the context of a complex disease,” Nature Biotechnology, vol. 22, no. 5, pp. 615–621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  214. D. M. Mutch, J. Tordjman, V. Pelloux et al., “Needle and surgical biopsy techniques differentially affect adipose tissue gene expression profiles,” American Journal of Clinical Nutrition, vol. 89, no. 1, pp. 51–57, 2009. View at Publisher · View at Google Scholar · View at Scopus